SPOTLIGHT -
Higher-Risk MDS Satellite Symposium
Program chair Navel Daver, MD, invites you to PER®’s complimentary in-person and virtual satellite symposium.
Naval G. Daver, MD, on the Past Year in Acute Myeloid Leukemia Research
The leukemia expert offered an overview of agents approved by the FDA this year.
Naval Daver, MD, Provides Perspective on Updates in Acute Myeloid Leukemia
Naval Daver, MD, explains the progress made on 3 abstracts he’s involved with regarding acute myeloid leukemia (AML) at the ASH Annual Meeting and Exposition.
The Emerging Profile of Immunotherapy Approaches in the Treatment of AML
Dr. Daver discusses immunotherapy approaches for patients with acute myeloid leukemia (AML), and his recent study results on the combination of azacitidine and nivolumab.
Immunotherapy Approaches in AML
Cancer Network sat down with Dr. Naval Daver to discuss advancements and discoveries in immunotherapy for AML patients.
